Results 301 to 310 of about 869,733 (343)

Megakaryocyte phenotyping in response to SARS-CoV-2 variants. [PDF]

open access: yesPlatelets
Sowa MA   +6 more
europepmc   +1 more source

Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
ABSTRACT Anticipating the evolution of septic patients with community‐acquired pneumonia (CAP) is challenging for front‐line physicians in the Emergency Department (ED). Prognosis depends mainly on early identification, antibiotics, organ support, but also immune status.
Thomas Lafon   +4 more
wiley   +1 more source

Rapid detection and quantification of ultralow‐concentration nanoparticles based on nanopore array blockage

open access: yesDroplet, EarlyView.
We developed a nanopore array strategy based on nanoparticle blockage for rapid detection and quantification of ultralow‐concentration nanoparticles. Using hydraulic force, nanoparticles are driven through an array of pores smaller than the nanoparticles, and optical microscopy tracks blockage progression to obtain quantitative concentration ...
Rami Yazbeck   +6 more
wiley   +1 more source

Understanding pathogen transmission on inanimate surfaces: Insights from respiratory fluid droplet composition and drying dynamics

open access: yesDroplet, EarlyView.
The graphical abstract shows the various phenomena the droplet undergo during evaporation, precipitation, and transfer to susceptible host. Abstract This study investigates how pathogen‐laden respiratory droplets transfer diseases via inanimate surfaces.
Abdur Rasheed   +5 more
wiley   +1 more source

Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins. [PDF]

open access: yesSci Rep
Costa M   +7 more
europepmc   +1 more source

Exploring the oncogenic potential of SARS-CoV-2 in the gastrointestinal tract. [PDF]

open access: yesWorld J Gastroenterol
Miteva DG   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy